AR030702A1 - Metodos y composicion para vacunacion oral - Google Patents

Metodos y composicion para vacunacion oral

Info

Publication number
AR030702A1
AR030702A1 ARP010102904A ARP010102904A AR030702A1 AR 030702 A1 AR030702 A1 AR 030702A1 AR P010102904 A ARP010102904 A AR P010102904A AR P010102904 A ARP010102904 A AR P010102904A AR 030702 A1 AR030702 A1 AR 030702A1
Authority
AR
Argentina
Prior art keywords
vaccine
animal
antigen
flavor
water
Prior art date
Application number
ARP010102904A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR030702A1 publication Critical patent/AR030702A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invencion abarca el uso de una mezcla de (a) un saborizante sabroso soluble en agua con un vehículo soluble en agua; y (b) un antígeno seleccionado entre el grupo que consiste en una bacteria y un virus como un componente activo de la vacuna administrada en forma oral para la manufactura de una formulacion de vacuna para la administracion oral para animales para proporcionar proteccion contra enfermedades asociadas con la infeccion por el antígeno en un animal y composiciones tanto para proporcionar proteccion contra enfermedades en un animal, como para inducir la incrementada ingestion de una vacuna administrada en forma oral, por un animal. Los métodos de la invencion están dirigidos a la mezcla de un antígeno bacteriano o viral con un saborizante sabroso soluble en agua a mezcla adicional de la mezcla de antígeno y saborizante con un vehículo soluble en agua para la administracion oral de la vacuna a un animal con el objetivo de proporcionar proteccion contra enfermedades asociadas con la infeccion por el antígeno mezclado, y la induccion de la incrementada ingestion de la vacuna con el saborizante. La presente invencion en consecuencia abarca métodos y composiciones para la vacunacion oral de animales sanos a través de agua de beber o jarabe como un auxiliar en la prevencion de enfermedades. La mezcla del saborizante sabroso proporciona una formulacion de vacuna con un sabor deseable, con el objetivo de promover la autoadministracion de la formulacion de vacuna y/o prevenir el rechazo de la formulacion cuando la administra un manipulador de animales.
ARP010102904A 2000-06-30 2001-06-19 Metodos y composicion para vacunacion oral AR030702A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21535900P 2000-06-30 2000-06-30

Publications (1)

Publication Number Publication Date
AR030702A1 true AR030702A1 (es) 2003-09-03

Family

ID=22802674

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010102904A AR030702A1 (es) 2000-06-30 2001-06-19 Metodos y composicion para vacunacion oral

Country Status (18)

Country Link
US (2) US20020025325A1 (es)
EP (1) EP1294399A2 (es)
JP (1) JP2004501979A (es)
KR (1) KR20030013480A (es)
CN (1) CN100457179C (es)
AR (1) AR030702A1 (es)
AU (2) AU7013501A (es)
BG (1) BG107282A (es)
BR (1) BR0111916A (es)
CZ (1) CZ20024222A3 (es)
HU (1) HUP0301394A3 (es)
MX (1) MXPA02012201A (es)
MY (1) MY128159A (es)
NZ (1) NZ523329A (es)
PL (1) PL360026A1 (es)
WO (1) WO2002002139A2 (es)
YU (1) YU99102A (es)
ZA (1) ZA200210402B (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7923023B2 (en) * 2002-02-25 2011-04-12 Astech International LLC Method and composition for delivery of medicants to animals
US8519008B2 (en) 2003-01-22 2013-08-27 Purina Animal Nutrition Llc Method and composition for improving the health of young monogastric mammals
US8637047B2 (en) * 2003-10-30 2014-01-28 Boehringer Ingelheim Vetmedica, Inc. Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same
US20050158367A1 (en) * 2004-01-16 2005-07-21 The Procter & Gamble Company Liquid compositions comprising one or more medicaments
US8834891B2 (en) * 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US8398994B2 (en) * 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
WO2007047728A2 (en) * 2005-10-20 2007-04-26 Wyeth Compositions and methods for the treatment of canine influenza virus disease
US8052971B2 (en) * 2005-11-21 2011-11-08 MG Biologics Oral use of specific antibodies for intestinal health
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
US8470336B2 (en) * 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
JPWO2008032796A1 (ja) 2006-09-13 2010-01-28 日本全薬工業株式会社 新規イヌ用ワクチン
US7674469B2 (en) * 2006-10-25 2010-03-09 Internet International B.V. Feline influenza vaccine and method of use
KR101099883B1 (ko) * 2006-12-27 2011-12-28 화이자 프로덕츠 인코포레이티드 백신 투여 방법
WO2009037262A2 (en) * 2007-09-17 2009-03-26 Boehringer Ingelheim Vetmedica, Inc. Method of preventing early lawsonia intracellularis infections
JP5257939B2 (ja) * 2009-02-24 2013-08-07 独立行政法人農業・食品産業技術総合研究機構 豚丹毒・豚マイコプラズマ肺炎経口投与型多価ワクチン
JP2012533557A (ja) * 2009-07-17 2012-12-27 ザ・ボード・オブ・リージェンツ・フォー・オクラホマ・ステート・ユニバーシティ 舌上ワクチン及びアプリケーター
US8453601B2 (en) * 2011-05-19 2013-06-04 C-Lock Inc. Vaccine and health-related applications for ruminant breath monitoring system
MX2015005491A (es) * 2012-11-05 2015-07-23 Nestec Sa Aguas potables saborizadas y metodos para mejorar la hidratacion para animales.
CA2905375A1 (en) * 2013-03-15 2014-09-18 Camas Incorporated Methods and compositions for reducing microorganisms in the oropharynx, nasopharynx and oral cavities
MX2017013715A (es) 2015-04-28 2018-03-02 Mars Inc Proceso de preparacion de un producto de alimento para mascotas humedo esterilizado.
JP7174698B2 (ja) * 2016-11-29 2022-11-17 インターベット インターナショナル ベー． フェー． ブタワクチン
NL2018155B1 (en) * 2017-01-11 2018-07-25 Intervet Int Bv Oral vaccine against ruminant respiratory disease
EP3554254A1 (en) 2016-12-15 2019-10-23 Société des Produits Nestlé S.A. Compositions and methods that modulate bacteria in a companion animal
US20220054616A1 (en) * 2019-01-04 2022-02-24 Boehringer Ingelheim Animal Health USA Inc. Attenuated Bordetella Bronchiseptica Strains, Oral Vaccines Containing the Attenuated Strains, and Methods of Making & Use Thereof
KR102234525B1 (ko) * 2020-08-28 2021-03-30 안병철 송아지의 점막관련 전염성 질병을 예방 또는 치료하기 위한 혈청의 제조방법, 상기 방법에 의해 제조된 혈청 및 이의 용도
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
CN115040468B (zh) * 2022-05-16 2023-02-07 中国农业科学院北京畜牧兽医研究所 一种中大体型动物口服免疫或给药“辣条”及其生产方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2966443A (en) * 1959-06-22 1960-12-27 American Cyanamid Co Trivalent poliomyelitis live virus vaccine
US3224941A (en) * 1963-01-21 1965-12-21 Lilly Co Eli Resin compositions and method for controlling diarrhea
GB1102676A (en) * 1965-10-08 1968-02-07 Hart Mfg Co H W Apparatus for supplying water to fowls
DE1792256C3 (de) * 1968-08-10 1979-07-05 Kali-Chemie Pharma Gmbh, 3000 Hannover Oral applizierbare, polyvalente Impfstoffe gegen lokale Darminfektionen
US4141229A (en) * 1977-10-11 1979-02-27 Stanly Knitting Mills, Inc. Knit cap with elastic head band
US5882649A (en) * 1990-04-24 1999-03-16 Flustat Pty. Ltd. Oral vaccine comprising antigen surface-associated with red blood cells
ATE183202T1 (de) * 1990-06-13 1999-08-15 Pfizer Pasteurella multocida toxoid enthaltende impfstoffe
US5846805A (en) * 1991-08-26 1998-12-08 Boehringer Ingelheim Animal Health, Inc. Culture of swine infertility and respiratory syndrome virus in simian cells
US5419907A (en) * 1992-11-10 1995-05-30 Iowa State University Research Foundation, Inc. Pathogenic porcine respiratory coronavirus
KR100304064B1 (ko) * 1993-08-12 2001-11-22 다카하시 미치나오 구강용조성물
FR2710500B1 (fr) * 1993-09-27 1995-12-01 Virbac Laboratoires Composition et système à administration orale pour animaux, leur procédé de préparation et leurs applications.
US6019982A (en) * 1994-08-26 2000-02-01 The Administrators Of The Tulane Educational Fund Mutant enterotoxin effective as a non-toxic oral adjuvant
US5985336A (en) * 1995-06-07 1999-11-16 Novus International, Inc. Nutrient formulation and process for feeding young poultry and other animals
US5884583A (en) * 1997-03-28 1999-03-23 Rhone Merieux, Inc. Field bag boost vaccination delivery system
US6100388A (en) * 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
US20020064517A1 (en) * 1998-04-30 2002-05-30 Stewart A. Cederholm-Williams Fibrin sealant as a transfection/transformation vehicle for gene therapy
BR9910438A (pt) * 1998-05-15 2001-01-02 Mkb Invest Ltd Partnership Composições e processos para imunização de aves domésticas
US6399074B1 (en) * 1998-07-24 2002-06-04 Megan Health, Inc. Live attenuated salmonella vaccines to control avian pathogens
US6713073B1 (en) * 1998-07-24 2004-03-30 Megan Health, Inc. Method of vaccination of newly hatched poultry
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
KR100324441B1 (ko) * 1999-02-08 2002-02-27 이은선 위염, 위궤양, 십이지장궤양 예방을 위한 식품
US6225304B1 (en) * 1999-02-17 2001-05-01 Pharmaceutical Solutions, Inc. Soluble forms of amoxicillin and treatment of animals
US7018638B2 (en) * 2000-12-19 2006-03-28 Wyeth Mycoplasma hyopneumoniae bacterin vaccine

Also Published As

Publication number Publication date
HUP0301394A3 (en) 2004-10-28
AU2001270135B2 (en) 2005-05-26
EP1294399A2 (en) 2003-03-26
HUP0301394A2 (hu) 2003-08-28
WO2002002139A3 (en) 2002-07-04
US20020025325A1 (en) 2002-02-28
US20060171960A1 (en) 2006-08-03
MXPA02012201A (es) 2003-06-06
JP2004501979A (ja) 2004-01-22
PL360026A1 (en) 2004-09-06
BG107282A (bg) 2003-06-30
NZ523329A (en) 2005-10-28
CN1529615A (zh) 2004-09-15
CZ20024222A3 (cs) 2003-06-18
YU99102A (sh) 2006-01-16
CN100457179C (zh) 2009-02-04
MY128159A (en) 2007-01-31
ZA200210402B (en) 2004-03-23
BR0111916A (pt) 2003-05-13
KR20030013480A (ko) 2003-02-14
WO2002002139A2 (en) 2002-01-10
AU7013501A (en) 2002-01-14

Similar Documents

Publication Publication Date Title
AR030702A1 (es) Metodos y composicion para vacunacion oral
Stepek et al. Human gastrointestinal nematode infections: are new control methods required?
US20160000845A1 (en) Extract of trigonella foenum-graecum
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
ES2946767T3 (es) Composiciones terapéuticas antimicrobianas hipertónicas
TNSN03155A1 (fr) Vaccination unidose avec mycoplasma hyopneumoniae
ES2398451T3 (es) Coadyuvante para vacunas
BRPI0913954A2 (pt) Composições adjuvantes
AR053680A1 (es) Composicion
CY1105202T1 (el) Διασπειρομενες φαρμακευτικες συνθεσεις
ES2591041T3 (es) Uso de EDTA y sus sales para la prevención y tratamiento de enfermedades intestinales bacterianas en cerdos
ES2605495T3 (es) Solución de atomoxetina
ES2769893T3 (es) Formulaciones de compuestos orgánicos volátiles que tienen actividad antimicrobiana
US10765650B2 (en) Artificial saliva
ES2758674T3 (es) Uso de taurina en la prevención y/o tratamiento de enfermedades inducidas por los virus del género coronavirus y/o del género rotavirus
US10143635B2 (en) Artificial saliva
CN103908423A (zh) 抗口腔幽门螺杆菌中药牙膏
CN101926796A (zh) 治疗犬皮肤真菌病的药物组合物及其制备方法
JPH02504389A (ja) 細菌性またはウイルス性疾患の予防および治療用医薬組成物
ES2928418T3 (es) Uso de vidofludimus para el tratamiento de infecciones por coronavirus
CN104940132B (zh) 一种硫酸小檗碱口服液及其制备方法
RU2592236C1 (ru) Способ лечения и профилактики нематодозов овец
US9468652B2 (en) Multipurpose dental gel
BRPI0419125A (pt) composição farmacêutica e processo para a preparação de uma composição farmacêutica
KR101825090B1 (ko) 리바비린 또는 그 유도체를 포함하는 구제역 치료용 조성물

Legal Events

Date Code Title Description
FB Suspension of granting procedure